drugset / Trial / NCT01608724
The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The efficacy and safety study of saxagliptin 5mg, once daily for 24 weeks in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2012-11
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 5 mg | Oral |